Palatin Technologies, Inc.
🏢 View company profile →66Patents
45Active
66Granted
50Portfolio score
Filing activity: Dec 15, 1999 → Jan 21, 2021 · 20 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6579968B1 | Compositions and methods for treatment of sexual dysfunction | Emerging Cross-Sectional Technologies | 46 | Expired |
| US6794489B2 | Compositions and methods for treatment of sexual dysfunction | Emerging Cross-Sectional Technologies | 28 | Expired |
| US6331285A | Structurally determined cyclic metallo-constructs and applications | Human Necessities | 27 | Expired |
| US7176279B2 | Cyclic peptide compositions and methods for treatment of sexual dysfunction | Emerging Cross-Sectional Technologies | 23 | Expired |
| US7342089B2 | Cyclic peptides for treatment for cachexia | Emerging Cross-Sectional Technologies | 17 | Expired |
| US7326707B2 | Bicyclic melanocortin-specific compounds | Physics | 14 | Expired |
| US7354923B2 | Piperazine melanocortin-specific compounds | Human Necessities | 14 | Expired |
| US7456184B2 | Melanocortin receptor-specific compounds | Chemistry; Metallurgy | 14 | Expired |
| US7795221B2 | Linear natriuretic peptide constructs | Human Necessities | 14 | Active |
| US7473760B2 | Cyclic peptide compositions for treatment of sexual dysfunction | Emerging Cross-Sectional Technologies | 13 | Expired |
| US8114844B2 | Linear and cyclic melanocortin receptor-specific peptidomimetics | Chemistry; Metallurgy | 13 | Active |
| US7235625B2 | Multiple agent therapy for sexual dysfunction | Emerging Cross-Sectional Technologies | 12 | Expired |
| US7345144B2 | Cyclic peptides for treatment of cachexia | Emerging Cross-Sectional Technologies | 12 | Expired |
| US7417027B2 | Linear and cyclic melanocortin receptor-specific peptides | Human Necessities | 12 | Expired |
| US7396814B2 | Metallopeptide compositions for treatment of sexual dysfunction | Human Necessities | 11 | Expired |
| US7968548B2 | Melanocortin receptor-specific piperazine compounds with diamine groups | Chemistry; Metallurgy | 11 | Active |
| US7049398B1 | Melanocortin metallopeptide constructs, combinatorial libraries and applications | Human Necessities | 11 | Expired |
| US8263608B2 | Melanocortin receptor-specific spiro-piperidine compounds | Human Necessities | 8 | Active |
| US8487073B2 | Melanocortin receptor-specific peptides for treatment of sexual dysfunction | Human Necessities | 7 | Active |
| US8492517B2 | Melanocortin-1 receptor-specific cyclic peptides | Human Necessities | 7 | Active |
| US8877890B2 | Melanocortin-1 receptor-specific cyclic peptides | Human Necessities | 7 | Active |
| US7097824B2 | Tuftsin metallopeptide analogs and uses thereof | Human Necessities | 7 | Expired |
| US7307063B2 | Melanocortin metallopeptides for treatment of sexual dysfunction | Human Necessities | 6 | Expired |
| US7807678B2 | Peptidomimetics of biologically active metallopeptides | Physics | 6 | Active |
| US7189755B2 | Pyrrolidine melanocortin-specific compounds | Physics | 5 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.